How Much Did GoodRx Raise?
Funding & Key Investors

GoodRx Holdings, Inc. has secured significant enterprise-level funding, with its total capital raised reaching $2.2B. The company recently announced a major strategic investment of $1.1B, underscoring its robust growth trajectory and market position in the digital health and prescription savings sector. This latest financing round is expected to fuel further expansion and innovation.

What is GoodRx?

GoodRx
SoftwareHealthcare SoftwareData Collection & Internet Portals

GoodRx operates a comprehensive price comparison platform designed to empower consumers in the United States to find savings on prescription medications. Founded in 2011 and headquartered in Santa Monica, California, the company provides geographically relevant prescription pricing and access to negotiated rates. Beyond its core price comparison tools, GoodRx has diversified its offerings to include subscription services, pharma manufacturer solutions, and telehealth services via its GoodRx Care platform. The company also engages with pharmacy benefit managers to optimize prescription transactions and pricing.

How much funding has GoodRx raised?

GoodRx has raised a total of $2.2B across 3 funding rounds:

2012

Angel/Seed

$1M

2020

Stock Offering

$1.1B

Stock Offering

$1.1B

Angel/Seed (2012): $1M with participation from Lerer Ventures, Highland Capital Partners, and SV Angel

Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed

Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed

Key Investors in GoodRx

Lerer Ventures

Lerer Ventures is an early-stage venture capital firm known for investing in innovative startups. They provide seed funding and strategic guidance to help companies establish a strong foundation for growth.

Highland Capital Partners

Highland Capital Partners is a venture capital firm with a history of successful investments in technology and healthcare sectors. They focus on partnering with entrepreneurs to scale disruptive businesses.

SV Angel

SV Angel is a venture capital firm committed to supporting founders through long-term partnerships. They offer strategic insights and network access to help companies achieve significant scale and market impact.

What's next for GoodRx?

The substantial enterprise-level funding and recent strategic investment signal GoodRx's intent to deepen its market penetration and enhance its service ecosystem. This capital infusion is likely to support the expansion of its telehealth capabilities, the development of new consumer-facing healthcare tools, and the strengthening of its relationships with pharmacy benefit managers and pharmaceutical partners. The company's focus on providing accessible and affordable healthcare solutions positions it for continued growth in an evolving market.

See full GoodRx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Security SoftwareSoftware
Security SoftwareSoftware
Content & Collaboration SoftwareSoftwareHuman Resources Software
Content & Collaboration SoftwareSoftware

Frequently Asked Questions Regarding GoodRx Financial Insights

What are the most recent funding rounds that GoodRx has completed, and what were the funding rounds?
GoodRx has recently completed 3 funding rounds: Stock Offering on Sep 23, 2020, Stock Offering on Sep 23, 2020, Angel/Seed on Feb 19, 2012.
What is the total amount of funding GoodRx has raised to date?
GoodRx has raised a total of $2.2B in funding to date.
How many funding rounds has GoodRx completed?
GoodRx has completed 3 funding rounds.
How much funding did GoodRx raise in its most recent funding round?
GoodRx raised $1.1B in its most recent funding round.
Which was the largest funding round in GoodRx's history?
The largest funding round in GoodRx's history was $1.1B.
See more information about GoodRx